The Hidden Link Between HIV and Cardiomyopathy: Unraveling HIV’s Impact on the Heart

For years, human immunodeficiency virus (HIV) was considered primarily an immunological threat. Still, advancements in HIV treatment leading to increased survival rates have revealed a significant and often overlooked complication: cardiomyopathy, a disease of the heart muscle. This review examines the complex relationship between HIV and cardiomyopathy, exploring the underlying mechanisms, clinical presentations, diagnostic approaches and treatment strategies.

The Growing Recognition of HIV-Associated Cardiovascular Disease

As individuals with HIV live longer, thanks to antiretroviral therapies, the incidence of cardiovascular disease (CVD) has risen. This shift in the landscape of HIV care has prompted increased attention to the long-term impact of the virus on cardiovascular health ¹. Cardiac involvement in AIDS patients has been reported in a substantial range, from 28% to 73% ².

Understanding the Pathogenesis of HIV-Associated Cardiomyopathy

The development of cardiomyopathy in individuals with HIV is multifaceted. Research suggests several contributing factors, including:

• Direct Viral Infection: HIV can directly infect cardiac cells, leading to inflammation, and damage.
• Inflammation: Chronic immune activation associated with HIV infection contributes to systemic inflammation, impacting the heart.
• Antiretroviral Therapy: While life-saving, some antiretroviral drugs have been linked to cardiac side effects.
• Co-infections: The presence of other infections common in individuals with HIV can exacerbate cardiac complications.

Recent advances in cardiac imaging and immunology are deepening our understanding of these complex processes ³.

Clinical Manifestations and Diagnosis

HIV-associated cardiomyopathy can manifest in various ways, including:

• Shortness of breath
• Fatigue
• Swelling in the legs and ankles
• Irregular heartbeat

Diagnosing HIV-associated cardiomyopathy requires a comprehensive evaluation, including:

• Echocardiography: An ultrasound of the heart to assess its structure and function.
• Electrocardiogram (ECG): To detect abnormal heart rhythms.
• Cardiac Magnetic Resonance Imaging (MRI): Provides detailed images of the heart muscle.
• Biomarkers: Blood tests to measure cardiac enzymes and other indicators of heart damage.

Treatment Strategies

Management of HIV-associated cardiomyopathy involves a combination of approaches:

• Antiretroviral Therapy: Suppressing HIV replication is crucial to reduce inflammation and viral load.
• Heart Failure Medications: Standard treatments for heart failure, such as ACE inhibitors, beta-blockers, and diuretics, may be used.
• Lifestyle Modifications: Adopting a heart-healthy diet, regular exercise, and smoking cessation are essential.

The Future of HIV and Heart Health

Ongoing research is focused on further elucidating the mechanisms underlying HIV-associated cardiomyopathy and developing targeted therapies. A comprehensive understanding of this complex interplay between HIV and the heart is vital for improving the long-term health and well-being of individuals living with HIV ⁴.